The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SAPHNELO anifrolumab 300 mg concentrated injection vial (350930)
ARTG Name
SAPHNELO anifrolumab 300 mg concentrated injection vial
Product name
SAPHNELO anifrolumab 300 mg concentrated injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
anifrolumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information